Want to improve your running time and distance? Do you have kids ready to join a sport? Torn ACL? See our wide range of sports medicine services. Learn more ›
Search by keyword or filter by cancer type to learn more about the numerous clinical trials and research studies underway at Providence Cancer Center. Learn more ›
For Providence Health Plan members– Now there is a less expensive option for health care from the comforts of home. Just answer some questions online and get a diagnosis and treatment plan from a Providence provider within an hour. Try SmartExam ›
Learn how and when to enroll in Medicare, understand costs and insurance options. Register now as space is limited.
Take a free health quiz to find out if you’re at risk for common health issues. In just a few minutes, you’ll get a personal health report, including recommendations on lifestyle changes.
Use Express Care Virtual to see a health care provider in minutes from your computer, smartphone or tablet.
OB-GYNs and certified nurse midwives offer you a lifetime of care – from your first well-woman exam to family planning, motherhood and through menopause.
In a powerful speech to a packed house, Becky Roth spoke emotionally about the cancer that changed, but didn’t claim, her life. And, despite losing two leg bones used for her jaw reconstruction – and against...
For people with advanced lung cancer, clinical trials open up new treatment options and offer access to promising new therapies. At Providence Cancer Institute, 19 studies of novel lung cancer therapies are open to...
Providence St. Vincent Medical Center was designated as a Magnet organization in 2000, 2004, 2009, and 2014 by the ANCC Magnet Recognition Program®. This prestigious designation recognizes excellence in nursing...
Krista Farnham has been named chief executive for Providence Portland Medical Center and will lead Providence Oregon’s eastern region.
Women with metastatic hormone-receptor-positive, HER2-negative breast cancer who have progressed after treatment with a CDK4/6 inhibitor may qualify for a newly opened immunotherapy study at Providence Cancer Institute.